A comparison between direct determination of in vivo dissolution and the deconvolution technique in humans

European Journal of Pharmaceutical Sciences

Volumn 8, Issue 1, 1999, Pages 19-27

  Bønløkke, Lisbet ^a   Hovgaard, Lars ^a   Kristensen, Henning G ^a   Knutson, Lars ^b   Lindahl, Anders ^b   Lennernäs, Hans ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Biopharmaceutic classification; Carbamazepine; In vitro in vivo correlations; In vivo dissolution; Intestinal perfusion

Indexed keywords

CARBAMAZEPINE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DISSOLUTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTESTINE PERFUSION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; SMALL INTESTINE; VOLUNTEER;

ALGORITHMS; ANTICONVULSANTS; AREA UNDER CURVE; BILE ACIDS AND SALTS; CARBAMAZEPINE; HUMANS; INTESTINAL ABSORPTION; JEJUNUM; KINETICS; PERFUSION; PERMEABILITY; SOLUBILITY; SUSPENSIONS;

EID: 0032978350     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(98)00055-4     Document Type: Article

References (29)

1. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. A theoretical basis for a Biopharmaceutical Drug Classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12(3):1995;413-420.
2. Bakatselou V., Oppenheim R.C., Dressman J.B. Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm. Res. 8(12):1991;1461-1469.
3. Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin. Pharmacokinet. 3:1978;128-143.
4. Bønløkke L., Christensen F.N., Knutson L., Kristensen H.G., Lennernäs H. A new approach for direct in vivo dissolution studies of poorly soluble drugs. Pharm. Res. 14(10):1997;1490-1492.
5. Charman W.N., Porter C.J.H., Mithani S., Dressman J.B. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci. 86:1997;269-282.
6. Dressman J.B., Amidon G.L., Reppas C., Shah V.P. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 15(1):1998;11-22.
7. Eichelbaum M., Ekblom K., Bertilsson L., Ringerberger V.A., Rane A. Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Eur. J. Clin. Pharmacol. 8:1975;337-341.
8. Gillespie W.R., Veng Pedersen P. Gastrointestinal bioavailability: determination of in vivo release profiles of solid oral dosage forms by deconvolution. Biopharm. Drug Dispos. 6:1985;351-355.
9. Hanano M. Studies on absorption and excretion of drug. VII. A new estimation method for the release of drug from dosage forms and the availability in vivo. Chem. Pharm. Bull. 15(7):1967;994-1001.
10. Hernell O., Staggers J.E., Carey M.C. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry. 29:1990;2041-2056.
11. Knutson L., Odlind B., Ryde M. A new technique for segmental jejunal perfusion in man. Am. J. Gastroenterol. 84:1989;1278-1284.
12. Langenbucher F. Numerical convolution/deconvolution as a tool for correlating in vitro with in vivo drug availability. Pharm. Ind. 44(11):1982;1166-1171.
13. Langenbucher F., Rettig H. Dissolution rate testing with the column method: methodology and results. Drug Dev. Ind. Pharm. 3(3):1977;241-263.
14. Lennernäs H., Ahrenstedt Ö., Hällgren R., Knutson L., Ryde M., Paalzow L.K. Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm. Res. 10:1992;1243-1251.
15. Lennernäs H., Knutson L., Lesko L., Salomonson T., Amidon G.L. Human effective permeability data for atenolol, metroprolol and carbamazepine to be used in the proposed biopharmaceutical classification for IR-products. Pharm. Res. 12:1995;S-295.
16. Lennernäs H., Lee I., Fagerholm U., Amidon G.L. A residence-time distribution analysis of the hydrodynamics within the intestine in man during a regional single-pass perfusion with Loc-I-Gut: in-vivo permeability estimation. J. Pharm. Pharmacol. 49:1997;682-686.
17. Levy R.H., Pitlick W.H., Troupin A.S., Green J.R., Neal J.M. Pharmacokinetics of carbamazepine in normal man. Clin. Pharmacol. Ther. 17:1975;657-668.
18. Lindahl A., Sandström R., Ungell A., Abrahamsson B., Knutson T.W., Knutson L., Lennernäs H. Jejunal permeability and hepatic extraction of fluvastatin in humans. Clin. Pharmacol. Ther. 60:1996;493-503.
19. Lindahl A., Ungell A., Knutson L., Lennernäs H. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm. Res. 14(4):1997;497-502.
20. Luhtala S. Effect of sodium lauryl sulphate and polysorbate 80 on crystal growth and aqueous solubility of carbamazepine. Acta Pharm. Nord. 4:1992;85-90.
21. Meyer M.C., Straughn A.B., Jarvi E.J., Wood G.C., Pelsor F.R., Shah V.P. The bioequivalence of carbamazepine tablets with a history of clinical failures. Pharm. Res. 12:1992;1612-1616.
22. Mira S., El-Sayed Y.M., Islam S.I. Simultaneous measurement of phenobarbital, carbamazepine, phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in serum by high-performance liquid chromatography. Analyst. 112:1987;57-60.
23. Neuvonen P.J. Bioavailability and central side effects of different carbamazepine tablets. Int. J. Clin. Pharmacol. Ther. Toxicol. 23:1985;226-232.
24. Nicklasson M., Graffner C., Nilsson M.-I. Assessment of in vivo drug dissolution by means of numerical deconvolution considering gastrointestinal availability. Int. J. Pharm. 40:1987;165-171.
25. Rawlins M.D., Collste P., Bertilsson L., Palmér L. Distribution and elimination kinetics of carbamazepine in man. Eur. J. Clin. Pharmacol. 8:1975;91-96.
26. Staggers J.E., Hernell O., Stafford R.J., Carey M.C. Physio-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry. 29:1990;2028-2040.
27. Verotta D. Deconvolution. Anaesth. Pharmacol. Rev. 2:1994;250-259.
28. Wagner J.G., Nelson E. Per cent absorbed time plots derived from blood level and/or urinary excretion data. J. Pharm. Sci. 52(6):1963;610-611.
29. Weintraub H., Gibaldi M. Physiological surface-active agents and drug absorption IV: Effect of pre-micellar concentrations of surfactant on dissolution rate. J. Pharm. Sci. 11:1969;1368-1372.